ADC Therapeutics
ADCT
#9013
Rank
โ‚ฌ0.16 B
Marketcap
1,17ย โ‚ฌ
Share price
-1.54%
Change (1 day)
-66.57%
Change (1 year)

EPS for ADC Therapeutics (ADCT)

EPS in 2026 (TTM): -0,57ย โ‚ฌ

According to ADC Therapeutics's latest financial reports the company's current EPS (TTM) is -0,60ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,09ย โ‚ฌ an increase over its 2024 EPS that were of -1,50ย โ‚ฌ.

EPS history for ADC Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,57ย โ‚ฌ-48.12%
2025-1,09ย โ‚ฌ-27.27%
2024-1,50ย โ‚ฌ
2022-1,83ย โ‚ฌ-33%
2021-2,73ย โ‚ฌ-17.21%
2020-3,30ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ 104.55%๐Ÿ‡บ๐Ÿ‡ธ USA